BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Eyetech Pharmaceuticals, Inc. 

666 Fifth Avenue, 35th Floor

New York  New York  10103  U.S.A.
Phone: 212-582-8376 Fax: 212 582-2645


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Big Pharma


Collaborations

Cell Matrix Inc. (Acquired By CancerVax)  Opthalmic applications of antibodies to denatured collagen





 Company News
OSI Pharmaceuticals, Inc. (OSIP) to Divest Eye-Disease Program 7/27/2007 10:58:19 AM
The Day In Review: OSI Pharmaceuticals, Inc. (OSIP) Gives Up On Macugen 11/7/2006 5:49:53 PM
Lux Biosciences Appoints To Board Of Directors David Guyer, SVLS Venture Partner And Former CEO Of Eyetech Pharmaceuticals, Inc. (EYET) 7/11/2006 12:55:45 PM
OSI Pharmaceuticals, Inc. (OSIP) To Host Conference Call To Discuss (OSI) Eyetech Pharmaceuticals, Inc. (EYET) Integration Strategy 11/16/2005 6:20:30 PM
OSI Pharmaceuticals, Inc. (OSIP) Completes Its Acquisition Of Eyetech Pharmaceuticals, Inc. (EYET) 11/14/2005 2:24:38 PM
OSI Pharmaceuticals, Inc. (OSIP) Updates Status Of Pending Acquisition Of Eyetech Pharmaceuticals, Inc. (EYET) 11/10/2005 1:27:37 PM
Eyetech Pharmaceuticals, Inc. (EYET) Merger Delayed Over Drug Concerns 11/10/2005 1:19:21 PM
Eyetech Pharmaceuticals, Inc. (EYET) Reports Third Quarter 2005 Financial Results 11/1/2005 11:20:39 AM
Eyetech Pharmaceuticals, Inc. (EYET) Announces Enrollment Of The First Patient In A Phase 3 Clinical Trial Of Macugen(R) (pegaptanib sodium injection) In Diabetic Macular Edema (DME) And Diabetic Retinopathy10/19/2005 5:13:22 PM
Eyetech Pharmaceuticals (EYET) Announces Co-Founder Marty Glick Steps Down From Board To Act As Consultant10/19/2005 5:13:14 PM
12345678910...